Biliary pronucleating proteins and apolipoprotein E in cholesterol and pigment stone patients

Journal of Hepatology

Volumn 39, Issue 1, 2003, Pages 7-11

  Van Erpecum, Karel J ^a,b   Portincasa, Piero ^a,c   Dohlu, Mehmet H ^d   Van Berge Henegouwen, Gerard P ^a   Jüngst, Dieter ^d  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

^c UNIVERSITY OF BARI   (Italy)

^d LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Apolipoprotein E; Bile; Gallstone; Mucin; Protein

Indexed keywords

APOLIPOPROTEIN E; BILE ACID; BILE SALT; CHOLESTEROL; HAPTOGLOBIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MUCIN; OROSOMUCOID; PIGMENT; PIGMENT STONE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BILE; CHEMISTRY; CHOLESTEROL STONE; CRYSTALLIZATION; FEMALE; GALLSTONE; GALLSTONE FORMATION; GENE FREQUENCY; GENETICS; GENOTYPE; HUMAN; LIPID ANALYSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN ANALYSIS;

EID: 0038649859     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(03)00177-6     Document Type: Article

References (37)

1. van Erpecum KJ, Portincasa P, Eckhardt E, Go PMNYH, van Berge-Henegouwen GP, Groen AK. Ursodeoxycholic acid reduces protein levels and nucleation-promoting activity in human gallbladder bile. Gastroenterology 1996;110:1225-37.
2. Wang DQH, Carey MC. Complete mapping of crystallization pathways during cholesterol precipitation from model bile: influence of physical-chemical variables of pathophysiologic significance and identification of a stable liquid-crystalline state in cold, dilute and hydrophilic bile salt-containing systems. J Lipid Res 1996;37:606-30.
3. Kesaniemi YA, Ehnholm C, Miettinen TA. Intestinal cholesterol absorption efficiency is related to apoprotein E phenotype. J Clin Invest 1987;80:578-81.
4. Weintraub MS, Eisenberg S, Breslov JL. Dietary fat clearance in normal subjects is regulated by genetic variation in apolipoprotein E. J Clin Invest 1987;80:1571-7.
5. Juvonen T, Kervinen K, Kairaluoma MI, Lajunen LHJ, Kesaniemi YA. Gallstone cholesterol content is related to apolipoprotein E polymorphism. Gastroenterology 1993;104:1806-13.
6. Bertomeu A, Ros E, Zambon D, Vela M, Perez-Ayuso RM, Targarona E, et al. Apolipoprotein E polymorphism and gallstones. Gastroenterology 1996;111:1603-10.
7. van Erpecum KJ, Carey MC. Apolipoprotein E4: another risk factor for cholesterol gallstone formation? Gastroenterology 1996;111:1764-7.
8. Portincasa P, van Erpecum KJ, van de Meeberg PC, Dallinga-Thie GM, De Bruin TWA, van Berge Henegouwen GP. Apolipoprotein E4 genotype and gallbladder motility influence speed of gallstone clearance and risk of recurrence after extracorporeal shock-wave lithotripsy. Hepatology 1996;24:580-7.
9. van Erpecum KJ, van Berge Henegouwen GP, Eckhardt ERM, Portincasa P, van de Heijning BJM, Dallinga-Thie GM, et al. Cholesterol crystallization in human gallbladder bile: relation to gallstone number, bile composition, and apolipoprotein E4 isoform. Hepatology 1998;27:1508-16.
10. Ko CW, Beresford SA, Alderman B, Jarvik GP, Schulte SJ, Calhoun B, et al. Apolipoprotein E genotype and the risk of gallbladder disease in pregnancy. Hepatology 2000;31:18-23.
11. Schirin-Sokhan R, Matern S, Lammert F. Human Lith genes: the gene encoding the multiligand receptor LRP2 is associated with cholecystolithiasis. Hepatology 2002;36:342A.
12. Hasegawa K, Tarada S, Kubota K, Itakura H, Ohnishi S, Imamura H, et al. Effect of apolipoprotein E polymorphism on bile lipid composition and the formation of cholesterol gallstone. Hepatology 2002;36:458A.
13. Niemi M, Kervinen K, Rantala A, Kauma H, Paivansalo M, Savolainen MJ, et al. The role of apolipoprotein E and glucose intolerance in gallstone disease in middle aged subjects. Gut 1999;44:557-62.
14. Fromm H, Hamin P, Klein H, Kupke I. Use of a simple enzymatic assay for cholesterol analysis in human bile. J Lipid Res 1980;21:259-61.
15. Fischer S, Dolu MH, Zundt B, Meyer G, Geisler S, Jüngst D. Apolipoprotein E polymorphism and lithogenic factors in gallbladder bile. Eur J Clin Invest 2001;31:789-95.
16. Bligh EG, Dyer WJ. A rapid method of total lipid extraction and purification. Can J Biochem Physiol 1959;37:911-7.
17. Turley SD, Dietschy JM. Reevaluation of the 3a-hydroxy-steroid dehydrogenase assay for total bile acids in bile. J Lipid Res 1978;19:924-8.
18. Carey MC. Critical tables for calculating the cholesterol saturation of native bile. J Lipid Res 1978;19:945-55.
19. Rossi SS, Converse JL, Hofmann AF. High pressure liquid chromatographic analysis of conjugated bile acids in human bile: simultaneous resolution of sulfated and unsulfated lithocholyl amidates and the common conjugated bile acids. J Lipid Res 1987;28:589-95.
20. Heuman DM. Quantitative estimation of the hydrophilic-hydrophobic balance of mixed bile salt solutions. J Lipid Res 1989;30:719-30.
21. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein using the principle of protein dye binding. Anal Biochem 1976;72:248-54.
22. Wessel D, Flügge UI. A method for the quantitative recovery of protein in dilute solution in the presence of detergents and lipids. Anal Biochem 1984;138:141-3.
23. Little GH, Starness WL, Behal FJ. Human liver aminopeptidase. In: Lorand L, editor. Methods in enzymology: proteolytic enzymes. New York: Academic Press; 1976, p. 495-503.
24. Miquel JF, Groen AK, van Wijland MJA, Del Pozo R, Eder MI, von Ritter C. Quantification of mucin in human gallbladder bile: a fast, specific and reproducible method. J Lipid Res 1995;36:2450-8.
25. Crowther RS, Wetmore RF. Fluorometric assay of O-linked glycoproteins by reaction with 2-cyanoacetamide. Anal Biochem 1987;163:170-4.
26. Holan KR, Holzbach RT, Hermann RE, Cooperman AM, Claffey WJ. Nucleation time: a key factor in the pathogenesis of cholesterol gallstone disease. Gastroenterology 1979;77:611-7.
27. Dallinga-Thie GM, van Linde-Sibenius M, Kock LAW, De Bruin TWA. Apolipoprotein E2/E3/E4 genotyping with agarose gels. Clin Chem 1995;41:73-5.
28. Smit M, de Knijff P, Rosseneu M, Bury J, Klasen E, Frants R, et al. Apolipoprotein E polymorphism in the Netherlands and its effect on plasma lipid and apolipoprotein levels. Hum Genet 1988;80:287-92.
29. Moschetta A, vanBerge-Henegouwen GP, Portincasa P, Palasciano G, van Erpecum KJ. Cholesterol crystallization in model biles: effects of bile salt and phospholipid species composition. J Lipid Res 2001;42:1273-81.
30. Klinkspoor JH, Kuver R, Savard CE, Oda D, Azzouz H, Tytgat GNJ, et al. Model bile and bile salts accelerate mucin secretion by cultured dog gallbladder epithelial cells. Gastroenterology 1995;109:264-74.
31. Sanabria JR, Upadhya A, Mullen B, Harvey PRC, Strasberg SM. Effect of deoxycholate on immunoglobulin G concentration in bile: studies in humans and pigs. Hepatology 1995;21:215-22.
32. van Erpecum KJ, Wang DQ-H, Lammert F, Paigen B, Groen AK, Carey MC. Phenotypic characterization of Lith genes that determine susceptibility to cholesterol cholelithiasis in inbred mice: soluble pronucleating proteins in gallbladder and hepatic biles. J Hepatol 2001;35:444-51.
33. Assmann G, Schmitz G, Menzel HJ, Schulte H. Apolipoprotein E polymorphism and hyperlipidemia. Clin Chem 1984;30:641-3.
34. Utermann G, Kindermann I, Kaffarnik H, Steinmetz A. Apolipoprotein E phenotypes and hyperlipidemia. Hum Genet 1984;65:232-6.
35. Walden CC, Hegele RA. Apolipoprotein E in hyperlipidemia. Ann Intern Med 1994;120:1026-36.
36. Mahley RW. Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science 1988;240:622-30.
37. van Erpecum KJ, vanBerge-Henegouwen GP, Stoelwinder B, Stolk MFJ, Eggink WF, Govaert WHA. Cholesterol and pigment gallstone disease: comparison of the reliability of three bile tests for differentiation between the two stone types. Scand J Gastroenterol 1988;23:948-54.